This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.48% per year. These returns cover a period from January 1, 1988 through May 5, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-growth: Archive
Is DXP Enterprises (DXPE) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
DXP Enterprises (DXPE) could produce exceptional returns because of its solid growth attributes.
DXPENegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Is Wheaton Precious Metals (WPM) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Wheaton Precious Metals (WPM) could produce exceptional returns because of its solid growth attributes.
WPMPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Commvault (CVLT) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Commvault (CVLT) could produce exceptional returns because of its solid growth attributes.
CVLTPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Brokers Suggest Investing in ConocoPhillips (COP): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in ConocoPhillips (COP). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
COPPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About PDD Holdings Inc. Sponsored ADR (PDD): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), PDD Holdings Inc. Sponsored ADR (PDD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PDDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About AGNC Investment (AGNC): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), AGNC Investment (AGNC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AGNCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Gilead (GILD) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Gilead (GILD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
GILDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Veeva (VEEV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
VEEVPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is CyberArk (CYBR) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CyberArk (CYBR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CYBRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Take-Two (TTWO) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Take-Two (TTWO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
TTWONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
3 Reasons Growth Investors Will Love Banco De Chile (BCH)
by Zacks Equity Research
Banco De Chile (BCH) possesses solid growth attributes, which could help it handily outperform the market.
BCHPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Should You Invest in TSMC (TSM) Based on Bullish Wall Street Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), TSMC (TSM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
TSMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Look Bullish on Axon (AXON): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Axon (AXON). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AXONPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Affirm Holdings (AFRM): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Affirm Holdings (AFRM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AFRMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Dell Technologies (DELL) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Dell Technologies (DELL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
DELLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Intuitive Surgical (ISRG) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ISRGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is CleanSpark (CLSK) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CleanSpark (CLSK) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CLSKNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Enterprise Products (EPD): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Enterprise Products (EPD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
EPDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL)
by Zacks Equity Research
Exelixis (EXEL) possesses solid growth attributes, which could help it handily outperform the market.
EXELNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
HealthEquity (HQY) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.
HQYNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Brokers Suggest Investing in Alibaba (BABA): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Alibaba (BABA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
BABANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Micron (MU): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Micron (MU) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MUPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Newmont (NEM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Newmont (NEM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
NEMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About UnitedHealth (UNH): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for UnitedHealth (UNH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
UNHPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in JD.com (JD): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for JD.com (JD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
JDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth